---
title: "Wegovy South Asian Safety Profile Differences | HealthRX.com"
description: "The Wegovy label reports pooled safety rates, not South Asian-specific ones. Nausea was 44% vs 16% on placebo. No ethnicity-based dose change."
url: https://healthrx.com/ethnicity-wegovy/south-asian--safety-differences
publisher: HealthRX.com
---


HealthRX.com

The label does not report safety separately by South Asian ethnicity

[Print or save as PDF](https://healthrx.com/printables/ethnicity-wegovy/south-asian--safety-differences?print=1)

Key numbers

- 44% vs 16% Nausea rate at 2.4 mg weekly, Wegovy vs placebo, pooled across all trial adults Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b), as cited Nov 7, 2026
- 73% vs 47% Any GI adverse reaction at 2.4 mg weekly, Wegovy vs placebo, pooled across all trial adults Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b), as cited Nov 7, 2026
- 0.25 mg Starting Wegovy weekly dose, held for 4 weeks before dose increases begin Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b), as cited Nov 7, 2026
- 6.8% vs 3.2% Stopping Wegovy due to adverse reactions, Wegovy vs placebo, pooled trial adults Source: [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b), as cited Nov 7, 2026

[See the public record for Semaglutide](https://healthrx.com/data/semaglutide)

HealthRX.com quick answer. The Wegovy label's adverse-reaction table pools all trial participants and the label sets no ethnicity-based dose adjustment, so it does not show whether safety differs in South Asian patients. At 2.4 mg weekly the pooled rates were nausea 44% vs 16% on placebo, vomiting 24% vs 6%, and any GI reaction 73% vs 47% [1]. The label warns about acute pancreatitis, gallbladder disease, hypoglycemia with insulin or a sulfonylurea, and kidney injury from fluid loss in all patients [1].

At a glance

- South Asian-specific safety data / Not reported separately in the Wegovy label [1]
- Nausea, 2.4 mg vs placebo / 44% vs 16% [1]
- Any GI adverse reaction / 73% vs 47% [1]
- Dose titration / Start 0.25 mg weekly for 4 weeks, increase every 4 weeks; maintenance 1.7 or 2.4 mg, up to 7.2 mg in some adults [1]
- WHO BMI action points / 23.0, 27.5, 32.5 and 37.5 kg/m² proposed in 2004; existing WHO cut-offs retained as international classifications [2]

## Does the Wegovy label report safety by South Asian ethnicity?

The label's 2.4 mg safety pool came from 3 placebo-controlled trials in adults with obesity or overweight, with 2,116 people on Wegovy and 1,261 on placebo, treated for up to 68 weeks [1]. Among the Wegovy-treated adults, 72% were White and 14% were Asian [1]. The adverse-reaction table gives one set of rates for the whole group. The label describes an Asian category in its baseline characteristics, not a South Asian one [1].

## What rates and warnings does the label give?

Nausea 44% vs 16%, diarrhea 30% vs 16%, vomiting 24% vs 6%, constipation 24% vs 11%, abdominal pain 20% vs 10%, dyspepsia 9% vs 3%, dizziness 8% vs 4%, hair loss 3% vs 1% and dysesthesia 2% vs 1% [1]. Severe GI reactions were 4.1% vs 0.9%, cholelithiasis 1.6% vs 0.7%, cholecystitis 0.6% vs 0.2%, and discontinuation for adverse reactions 6.8% vs 3.2% [1]. The label says to discontinue Wegovy if pancreatitis is suspected, to do gallbladder studies if cholelithiasis is suspected, and to consider reducing insulin or an insulin secretagogue when starting Wegovy to reduce hypoglycemia risk [1]. Acute kidney injury from volume depletion occurred in 0.4 vs 0.2 cases per 100 patient-years (7 vs 4 adults) [1].

Questions worth asking

Choose the questions you want to keep Does the label list any warnings that apply to all patients regardless of background? Which side effects should I ask my prescriber about first when starting Wegovy? Should my prescriber check my fluid intake and kidney function if vomiting or diarrhea starts on Wegovy? What symptoms of pancreatitis or gallbladder problems mean I should stop Wegovy and call my prescriber? If I take insulin or a sulfonylurea, how should my dose be reviewed before I start Wegovy? Is there any ethnicity-specific data on Wegovy side effects I can ask my prescriber to show me?

## Does the BMI discussion change Wegovy eligibility?

The US Wegovy label indicates weight reduction for adults and children 12 and older with obesity, and for adults with overweight plus at least one weight-related condition. It does not set a South Asian-specific threshold [1]. WHO's 2004 expert consultation retained the existing WHO BMI cut-off points as international classifications and proposed 23.0, 27.5, 32.5 and 37.5 kg/m² as additional public health action points for Asian populations [2]. In two US cohorts, 43.6% of normal-weight South Asian participants had two or more cardiometabolic abnormalities vs 21.0% of white participants. The prevalence seen at BMI 25.0 in white participants corresponded to a BMI of 19.6 in South Asian participants [3]. That cohort study did not measure semaglutide side effects, so it does not change the label's rates or warnings [3][1].

## How is Wegovy dosed?

Wegovy injection starts at 0.25 mg once weekly for 4 weeks, then increases every 4 weeks [1]. Maintenance depends on the indication. For weight reduction, 2.4 mg is recommended with 1.7 mg as an alternative. CV risk reduction uses 2.4 mg or 1.7 mg, and MASH uses 2.4 mg, which may be reduced to 1.7 mg [1]. Adults who tolerate 2.4 mg for at least 4 weeks and need more weight loss may increase to a maximum of 7.2 mg weekly. The pediatric maximum is 2.4 mg [1]. The label's dosing instructions contain no ethnicity-based adjustment [1].

Check what you know

Think you have it? Try 3 quick questions and see what the article says.

1. How does the label say Wegovy injection dosing starts?

Question 1 of 3

Score: 0 right, 0 of 3 answered

Printable side-effect diary

Wegovy side effect diary for South Asian patients

Use this sheet to record Wegovy doses and side effects by hand, then bring it to your prescriber or pharmacist. It covers the nausea, vomiting, stomach, gallbladder, low blood sugar and fluid loss topics that the article says the label reports for all patients.

[Open the fill-in sheet](https://healthrx.com/printables/ethnicity-wegovy/south-asian--safety-differences) Fill it in, print it or save it as a PDF. No sign-up.

Frequently asked questions

Are Wegovy side effects worse in South Asian patients?

That is not known from the label, which reports pooled rates rather than South Asian-specific rates. At 2.4 mg, nausea occurred in 44% on Wegovy vs 16% on placebo and vomiting in 24% vs 6% [1].

Does the Wegovy dose schedule differ by ethnicity?

No ethnicity-based adjustment appears in the label. Injection starts at 0.25 mg weekly for 4 weeks and increases every 4 weeks; maintenance is 1.7 or 2.4 mg depending on the indication, and some adults may increase to 7.2 mg after tolerating 2.4 mg for at least 4 weeks and needing more weight loss [1].

Does Wegovy make oral contraceptives less effective?

The semaglutide labels carry no advice to switch contraception or add a barrier method. An interaction study with semaglutide tablets found no clinically significant effect on ethinyl estradiol or levonorgestrel exposure [1].

Is pancreatitis a special concern for South Asian patients on Wegovy?

The label warns about acute pancreatitis in all patients and says to discontinue Wegovy if it is suspected; it does not stratify that warning by ethnicity [1].

Reader questions

What people actually ask

Short answers drawn from the sources this article cites.

What are the weird side effects with Wegovy?

The most common side effects on 2.4 mg weekly are gastrointestinal. Nausea occurred in 44% on Wegovy vs 16% on placebo, diarrhea in 30% vs 16%, vomiting in 24% vs 6%, and constipation in 24% vs 11%. Dizziness (8% vs 4%), hair loss (3% vs 1%) and dysesthesia (2% vs 1%) also appeared.

Does Wegovy have bad long term effects?

This is not established by the label text. The safety pool came from placebo-controlled trials treated for up to 68 weeks, so the reported rates cover only that period.

References

Show all 3 references Hide references

1. U.S. National Library of Medicine, DailyMed. Wegovy injection and Wegovy tablets (Novo Nordisk) prescribing information. [Wegovy injection and Wegovy tablets (Novo Nordisk) label](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
2. WHO Expert Consultation. [Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies](https://pubmed.ncbi.nlm.nih.gov/14726171/). Lancet. 2004;363(9403):157-63.
3. Gujral UP, Vittinghoff E, Mongraw-Chaffin M, Vaidya D, Kandula NR, Allison M, et al. [Cardiometabolic Abnormalities Among Normal-Weight Persons From Five Racial/Ethnic Groups in the United States: A Cross-sectional Analysis of Two Cohort Studies](https://pubmed.ncbi.nlm.nih.gov/28384781/). Ann Intern Med. 2017;166(9):628-636.

Next in this cluster

Related reading

- [semaglutide Wegovy cardiovascular prevention](https://healthrx.com/off-label-wegovy/cardiovascular-prevention--monitoring)
- [semaglutide Wegovy Self-Injection](https://healthrx.com/wegovy/self-injection-technique)
- [semaglutide Wegovy cardiovascular prevention](https://healthrx.com/off-label-wegovy/cardiovascular-prevention--dosing-protocol)
- [semaglutide Semaglutide 2.4 mg Off-Label](https://healthrx.com/wegovy/off-label-uses)
- [semaglutide Wegovy alcohol](https://healthrx.com/lifestyle-wegovy/alcohol)
- [semaglutide Do You Need to Exercise on Wegovy?](https://healthrx.com/lifestyle-wegovy/exercise)
- [semaglutide Wegovy life events](https://healthrx.com/lifestyle-wegovy/life-events)
- [semaglutide Wegovy Nutrition for Best Outcomes](https://healthrx.com/lifestyle-wegovy/nutrition)
- [semaglutide Wegovy relationships](https://healthrx.com/lifestyle-wegovy/relationships)
- [semaglutide Wegovy sleep](https://healthrx.com/lifestyle-wegovy/sleep)
- [semaglutide Wegovy travel](https://healthrx.com/lifestyle-wegovy/travel)
- [semaglutide Wegovy workplace](https://healthrx.com/lifestyle-wegovy/workplace)
- [wegovy semaglutide Semaglutide injection site reaction](https://healthrx.com/side-effects-wegovy-injection-site-reactions/biology)
- [semaglutide Does blue cross blue shield cover Wegovy](https://healthrx.com/glp-1-questions/does-blue-cross-blue-shield-cover-semaglutide-wegovy)

![wegovy South Asian safety: woman eating a light breakfast to ease nausea](https://zwulxpn434zaufgz.public.blob.vercel-storage.com/page-images/ethnicity-wegovy/south-asian--safety-differences.webp)

Smaller, lighter meals are a common way to manage the nausea the label reports across all trial participants. Full Wegovy South Asian guide and sources at [healthrx.com/ethnicity-wegovy](https://healthrx.com/ethnicity-wegovy).
